Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 12;34(1):45-50.
doi: 10.1515/jpem-2020-0386. Print 2021 Jan 27.

Effectiveness of basal LH in monitoring central precocious puberty treatment in girls

Valeria Calcaterra  1   2 , Gianpaolo De Filippo  3   4 , Riccardo Albertini  5 , Domenico Rendina  6 , Beatrice Messini  7 , Claudio Maria Monti  8 , Elena Bozzola  9 , Alberto Villani  9 , Mauro Bozzola  10   11
Affiliations

Effectiveness of basal LH in monitoring central precocious puberty treatment in girls

Valeria Calcaterra et al. J Pediatr Endocrinol Metab. .

Abstract

Objectives: Treatment of central precocious puberty (CPP) is based on administration of GnRH agonists in order to suppress hypothalamic-pituitary-gonadal axis and thus induce the stabilization or regression of pubertal development. Our aim was to determine whether the single basal serum LH and/or FSH concentration could be an effective tool to assess the efficacy of treatment to suppress activation of hypothalamic-pituitary axis.

Patients and methods: Serum LH and FSH were measured before and after the GnRH injection, as well as E2 basal levels in 60 girls with documented idiopathic CPP at diagnosis and 18 and 30 months after the beginning of therapy.

Results: At diagnosis, peaks of >5 IU/L of LH and of FSH were observed in 100 and 91.6% of girls, respectively, with basal LH values of <1 IU/L in 70% and basal FSH levels of <1 IU/L in 10%. E2 were <20 pg/mL in 36.6%. After 18 months, a suppressed peak (i.e. <3 IU/L) was recorded in 85% of girls (p<0.01) for LH and in 98.3% for FSH (p<0.01). Basal LH <1 IU/L was detected in 85% (p<0.01) and basal FSH ≤1 IU/L in 40% (p<0.01). Serum E2 ≤20 pg/mL was recorded in 61.6% (p<0.01). After 30 months, all patients showed LH suppressed peak (p<0.01) and 98.3% suppressed FSH peak (p<0.01). 100% showed basal LH concentrations <1 IU/L (p<0.01) and 38.3% FSH basal values <1 UI/mL (p<0.01). E2 ≤20 pg/mL was observed in 32.72% (p=NS).

Conclusions: Basal LH values are a reliable indicator of the efficacy of GnRHa therapy after 30 months of GnRHa therapy.

Keywords: FSH; GnRH; GnRH analog (GnRHa); LH; monitoring; precocious puberty; puberty.

PubMed Disclaimer

References

    1. Carel, JC, Léger, J. Clinical practice. Precocious puberty. N Engl J Med 2008;358:2366–77. https://doi.org/10.1056/nejmcp0800459.
    1. Herger, S, Muller, R, Ranke, M, Schwarz, P-H, Waldhauser, F, Partsch, C-J, et al.. Long-term GnRH agonist treatment for female CPP does not impair reproductive function. Mol Cell Endocrinol 2006;254–255:217–20.
    1. Lee, DS, Ryoo, NY, Lee, SH, Kim, S, Kim, JH. Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls? Ann Pediatr Endocrinol Metab 2013;18:196–201. https://doi.org/10.6065/apem.2013.18.4.196.
    1. Carel, J. C, Eugster, E. A, Rogol, A, Ghizzoni, L, Palmert, M. R. ESPE-LWPES GnRH Analogs Consensus Conference Group. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 2009;123:e752. e762. https://doi.org/10.1542/peds.2008-1783.
    1. Kanthi Bangalore, K, Fuqua, JS, Rogol, AD, Klein, KO, Popovic, J, Houk, CP, et al.. Use of gonadotropin-releasing hormone analogs in children: update by an international consortium. Horm Res Paediatr 2019;91:357–72. https://doi.org/10.1159/000501336.

LinkOut - more resources